x

Coronavirus

Oxford Vaccine Trial Continues Amid Death Report

October 22, 2020

LONDON — The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant's death.

The university said it can’t comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial.

It says an “independent review, in addition to the Brazilian regulator, have recommended that the trial should continue.”

The Oxford vaccine is being developed in conjunction with the international pharmaceutical company AstraZeneca. Trials are underway in the United States and the U.K., as well as Brazil, to determine whether the potential vaccine is safe and effective in humans.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Woman Fatally Shot while Pushing Stroller on Upper East Side

NEW YORK — A 20-year-old woman was fatally shot Wednesday night while she pushed her infant daughter in a stroller on the Upper East Side, police said.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.